pioglitazone has been researched along with natriuretic peptide, brain in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (75.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, K; Irukayama-Tomobe, Y; Miyauchi, T; Ogata, T; Sakai, S; Yamaguchi, I | 1 |
| Ito, S; Ogawa, S; Takeuchi, K | 1 |
| Maeda, T; Makino, N; Oyama, J; Satoh, S; Sugano, M | 1 |
| Dorkhan, M; Frid, A; Groop, L; Grubb, A; Jovinge, S; Magnusson, M | 1 |
| Sheng, L; Wu, SM; Yang, W; Ye, P | 1 |
| Balaska, A; Kakavas, N; Karagiannis, A; Koulas, G; Kountana, E; Sambanis, C; Tziomalos, K; Zamboulis, C; Zografou, I | 1 |
| Ishida, A; Nakamoto, M; Ohya, Y; Shinzato, T; Takishita, S | 1 |
| Cheng, XW; Kato, MF; Koike, Y; Miyachi, M; Murate, T; Murohara, T; Nagata, K; Nishizawa, T; Noda, A; Obata, K; Shibata, R; Tsuboi, K; Yamada, T; Yazawa, H; Yokota, M | 1 |
| Burnier, M; Deleaval, P; Jornayvaz, FR; Maillard, M; Nussberger, J; Pechere-Bertschi, A; Vinciguerra, M; Zanchi, A | 1 |
| Liu, YX; Wu, SM; Ye, P; Zhang, C | 1 |
| Baldus, S; Behringer, A; Berghausen, EM; Blaschke, F; Caglayan, E; Er, F; Gassanov, N; Kappert, K; Odenthal, M; Rosenkranz, S; Ten Freyhaus, H; Trappiel, M; Wellnhofer, E | 1 |
| Adachi, H; Katsuyama, H; Yanai, H | 1 |
3 trial(s) available for pioglitazone and natriuretic peptide, brain
| Article | Year |
|---|---|
Plasma BNP levels in the treatment of type 2 diabetes with pioglitazone.
Topics: Aged; Atrial Natriuretic Factor; Body Mass Index; Buformin; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Heart Failure; Humans; Hypoglycemic Agents; Male; Middle Aged; Natriuretic Peptide, Brain; Pioglitazone; Stroke Volume; Thiazoles; Thiazolidinediones | 2003 |
Glycaemic and nonglycaemic effects of pioglitazone in triple oral therapy of patients with type 2 diabetes.
Topics: Adiponectin; Administration, Oral; Aged; Biomarkers; Blood Glucose; Case-Control Studies; Cystatin C; Cystatins; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pioglitazone; Proinsulin; Prospective Studies; Statistics, Nonparametric; Thiazolidinediones | 2006 |
Effects of the peroxisome proliferator-activated receptor (PPAR)-gamma agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individuals.
Topics: Analysis of Variance; Blood Pressure; Body Weight; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypertension; Hypoglycemic Agents; Insulin Resistance; Male; Metformin; Natriuretic Peptide, Brain; Pioglitazone; Sodium, Dietary; Thiazolidinediones | 2010 |
9 other study(ies) available for pioglitazone and natriuretic peptide, brain
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor-gamma activators inhibit endothelin-1-related cardiac hypertrophy in rats.
Topics: Analysis of Variance; Animals; Cardiomegaly; Chromans; Endothelin-1; Endothelins; Male; Natriuretic Peptide, Brain; Pioglitazone; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stimulation, Chemical; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2002 |
Peroxisome proliferator-activated receptor-gamma ligands attenuate brain natriuretic peptide production and affect remodeling in cardiac fibroblasts in reoxygenation after hypoxia.
Topics: Angiotensin II; Animals; Animals, Newborn; Blotting, Northern; Blotting, Western; Cell Hypoxia; Cells, Cultured; Collagen Type I; Collagen Type III; Electrophoretic Mobility Shift Assay; Fibroblasts; Gene Expression; Ligands; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Muscle Cells; Myocardial Reperfusion Injury; Myocardium; Natriuretic Peptide, Brain; NF-kappa B; Oxygen; Pioglitazone; PPAR gamma; Prostaglandin D2; Rats; Rats, Wistar; RNA, Messenger; Thiazolidinediones; Tissue Inhibitor of Metalloproteinase-1 | 2006 |
Effect of pioglitazone on the expression of inflammatory cytokines in attenuating rat cardiomyocyte hypertrophy.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Interleukin-1beta; Interleukin-6; Leucine; Myocytes, Cardiac; Natriuretic Peptide, Brain; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; RNA, Messenger; Thiazolidinediones | 2006 |
Effect of pioglitazone on heart function and N-terminal pro-brain natriuretic peptide levels of patients with type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Echocardiography; Female; Heart; Humans; Hypoglycemic Agents; Lipids; Liver Function Tests; Male; Metformin; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pioglitazone; Thiazolidinediones | 2008 |
Beneficial effects of pioglitazone on left ventricular hypertrophy in genetically hypertensive rats.
Topics: Animals; Blood Glucose; Blood Pressure; Collagen Type I; Collagen Type III; Connective Tissue Growth Factor; Echocardiography; Hypertension; Hypertrophy, Left Ventricular; Hypoglycemic Agents; Immediate-Early Proteins; Insulin; Intercellular Signaling Peptides and Proteins; Male; Matrix Metalloproteinases; Natriuretic Peptide, Brain; Organ Size; Pioglitazone; PPAR gamma; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; RNA, Messenger; Thiazolidinediones; Transforming Growth Factor beta1 | 2007 |
Pioglitazone attenuates cardiac hypertrophy in rats with salt-sensitive hypertension: role of activation of AMP-activated protein kinase and inhibition of Akt.
Topics: Adiponectin; AMP-Activated Protein Kinases; Animals; Atrial Natriuretic Factor; Collagen; Echocardiography; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Hypoglycemic Agents; Male; Multienzyme Complexes; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Phosphorylation; Pioglitazone; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred Dahl; Ribosomal Protein S6 Kinases, 70-kDa; RNA, Messenger; Signal Transduction; Thiazolidinediones; Transcription Factors | 2008 |
[Pioglitazone inhibits cardiac hypertrophy of rats in vitro and in vivo].
Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Cell Line; Cytokines; Disease Models, Animal; Interleukin-1beta; Male; Myocytes, Cardiac; Natriuretic Peptide, Brain; Pioglitazone; Rats; Rats, Sprague-Dawley; RNA, Messenger; Thiazolidinediones | 2005 |
Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
Topics: Animals; Arterial Pressure; Cardiovascular Agents; Disease Models, Animal; Fibrosis; Heart Ventricles; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Macrophages, Alveolar; Male; Monocrotaline; Myocytes, Cardiac; Natriuretic Peptide, Brain; Osteopontin; Pioglitazone; PPAR gamma; Pulmonary Artery; Rats, Sprague-Dawley; Thiazolidinediones; Vascular Remodeling; Ventricular Function, Right; Ventricular Remodeling | 2016 |
The low dose (7.5mg/day) pioglitazone is beneficial to the improvement in metabolic parameters without weight gain and an increase of risk for heart failure.
Topics: Aged; Diabetes Mellitus, Type 2; Female; Heart Failure; Humans; Hypoglycemic Agents; Male; Middle Aged; Natriuretic Peptide, Brain; Pioglitazone; Retrospective Studies; Thiazolidinediones; Weight Gain | 2017 |